DJIA 17,675.19 -100.93 -0.57%
NASDAQ 4,860.14 -40.75 -0.83%
S&P 500 2,057.58 -10.31 -0.50%
market minute promo

Novavax, Inc. (NASDAQ: NVAX)

8.14 -0.13 (-1.57%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

NVAX $8.13 -1.69%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $8.24
Previous Close $8.27
Daily Range $7.92 - $8.32
52-Week Range $3.34 - $9.95
Market Cap $1.9B
P/E Ratio -22.35
Dividend (Yield) $0.00 (0.0%)
Volume 2,831,099
Average Daily Volume 5,599,362
Current FY EPS -$0.45




Drug Makers

Novavax, Inc. (NVAX) Description

A biopharmaceutical company focused on creating differentiated, value-added vaccines that improve upon current preventive options for a range of infectious diseases. Website:

News & Commentary

3 Biotech Stocks That Dropped Yesterday -- Is 1 a Buy?

Esperion Therapeutics, Inc, Novavax, Inc., and Ziopharm are all seeing their shares drop sharply this week.

What Makes Novavax (NVAX) a Strong Sell? - Tale of the Tape

Use Options For a Chance To Buy NVAX at a 44% Discount

8 Analyst Stocks Under $10 With Huge Upside Targets

Friday's ETF Movers: FBT, XOP

Novavax (NVAX) Marked As A Dead Cat Bounce Stock

Morning Market Losers

Benzinga's Top #PreMarket Losers

Novavax (NVAX) Stock Declines Today After Announcing $175 Million Public Stock Offering

Morning Market Losers

See More NVAX News...

NVAX's Top Competitors

NVAX $8.14 (-1.57%)
Current stock: NVAX
AMGN $155.78 (-2.55%)
Current stock: AMGN
GILD $96.53 (-1.63%)
Current stock: GILD
BIIB $412.35 (-2.34%)
Current stock: BIIB